PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 153 filers reported holding PROTAGONIST THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.62 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $154,207 | -42.5% | 9,245 | -4.8% | 0.00% | 0.0% |
| Q2 2023 | $268,190 | +14.8% | 9,710 | -4.4% | 0.00% | 0.0% |
| Q1 2023 | $233,680 | +150.9% | 10,160 | +19.0% | 0.00% | – |
| Q4 2022 | $93,128 | +52.7% | 8,536 | +18.6% | 0.00% | – |
| Q3 2022 | $61,000 | +7.0% | 7,199 | 0.0% | 0.00% | – |
| Q2 2022 | $57,000 | -66.5% | 7,199 | 0.0% | 0.00% | -100.0% |
| Q1 2022 | $170,000 | -20.9% | 7,199 | +14.4% | 0.00% | 0.0% |
| Q4 2021 | $215,000 | +400.0% | 6,293 | +159.1% | 0.00% | – |
| Q3 2021 | $43,000 | – | 2,429 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $56,331,209 | 18.32% |
| Kynam Capital Management, LP | 1,375,000 | $31,625,000 | 4.08% |
| BVF INC/IL | 3,775,900 | $86,845,700 | 3.18% |
| Cormorant Asset Management, LP | 1,700,000 | $39,100 | 2.58% |
| RTW INVESTMENTS, LP | 4,600,799 | $105,818,377 | 2.20% |
| Ghost Tree Capital, LLC | 225,000 | $5,175,000 | 1.53% |
| 683 Capital Management, LLC | 791,000 | $18,193,000 | 1.36% |
| Ikarian Capital, LLC | 211,400 | $4,862,200 | 1.10% |
| Ikarian Capital, LLC | 211,400 | $4,862,200 | 1.10% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 105,486 | $2,426,178 | 1.00% |